These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2717513)

  • 1. Isolation of a novel morphinan 3-O-diglucuronide metabolite from dog urine.
    Dixon R; Hsiao J; Hsu HB; Smulkowski M; Tze-Ming-Chan ; Pramanik B; Morton J
    Pharm Res; 1989 Jan; 6(1):28-32. PubMed ID: 2717513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of the opioid antagonist, nalmefene, in rat and dog.
    Murthy SS; Mathur C; Kvalo LT; Lessor RA; Wilhelm JA
    Xenobiotica; 1996 Jul; 26(7):779-92. PubMed ID: 8819305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of morphine and its surrogates V: Naltrexone and naltrexone conjugate pharmacokinetics in the dog as a function of dose.
    Garrett ER; el-Koussi A el-D
    J Pharm Sci; 1985 Jan; 74(1):50-6. PubMed ID: 3981418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
    France CP; Gerak LR
    J Pharmacol Exp Ther; 1994 Sep; 270(3):992-9. PubMed ID: 7932212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.
    Malspeis L; Bathala MS; Ludden TM; Bhat HB; Frank SG; Sokoloski TD; Morrison BE; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates.
    Simpkins JW; Smulkowski M; Dixon R; Tuttle R
    J Pharmacol Exp Ther; 1988 Jan; 244(1):195-205. PubMed ID: 3335997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalmefene: quantitation of a new narcotic antagonist in human plasma using high performance-liquid chromatography with electrochemical detection.
    Hsiao J; Dixon R
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):449-54. PubMed ID: 6665302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nalmefene: intravenous safety and kinetics of a new opioid antagonist.
    Dixon R; Howes J; Gentile J; Hsu HB; Hsiao J; Garg D; Weidler D; Meyer M; Tuttle R
    Clin Pharmacol Ther; 1986 Jan; 39(1):49-53. PubMed ID: 3943269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and identification of the glucuronide conjugate of 2-hydroxydesipramine by preparative liquid chromatography.
    Suckow RF; Cooper TB
    J Chromatogr; 1988 Jun; 427(2):287-94. PubMed ID: 3410912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of naltrexone hydrochloride and naltrexone glucuronide in the dog].
    Li H; Zhao SF; Wang N; Ge ZH
    Yao Xue Xue Bao; 1996; 31(4):254-7. PubMed ID: 9208648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of metaproterenol-3-O-sulfate: a conjugate of metaproterenol in human urine.
    MacGregor TR; Nastasi L; Farina PR; Keirns JJ
    Drug Metab Dispos; 1983; 11(6):568-73. PubMed ID: 6140141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of nalmefene on LH, prolactin, and testosterone in male rhesus monkeys.
    Mello NK; Mendelson JH; Kelly M
    Pharmacol Biochem Behav; 2000 Jun; 66(2):275-83. PubMed ID: 10880679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electromembrane extraction of trace amounts of naltrexone and nalmefene from untreated biological fluids.
    Rezazadeh M; Yamini Y; Seidi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1143-8. PubMed ID: 21493167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a glucuronide metabolite of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats.
    Morse MA; Eklind KI; Toussaint M; Amin SG; Chung FL
    Carcinogenesis; 1990 Oct; 11(10):1819-23. PubMed ID: 2208595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid. Rearrangement of the 1-o-acyl glucuronide.
    Janssen FW; Kirkman SK; Fenselau C; Stogniew M; Hofmann BR; Young EM; Ruelius HW
    Drug Metab Dispos; 1982; 10(6):599-604. PubMed ID: 6130907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an O-glucuronide metabolite of the CCK-B antagonist LY288513 and its plasma levels in mouse, rat, and dog.
    Woodland JM; Ehlhardt WJ
    Drug Metab Dispos; 1995 Sep; 23(9):910-5. PubMed ID: 8565780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gas-liquid chromatographic method for the determination of naltrexone and beta-naltrexol in human urine.
    Verebely K; Mulé SJ; Jukofsky D
    J Chromatogr; 1975 Aug; 111(1):141-8. PubMed ID: 239958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.